首页 | 本学科首页   官方微博 | 高级检索  
     

BIOMED-2体系检测免疫球蛋白重链基因重排在黏膜相关淋巴组织结外边缘区B细胞淋巴瘤诊断中的应用
引用本文:刘宏艳,薛丽燕,应建明,邱田,邹霜梅,吕宁. BIOMED-2体系检测免疫球蛋白重链基因重排在黏膜相关淋巴组织结外边缘区B细胞淋巴瘤诊断中的应用[J]. 白血病.淋巴瘤, 2012, 21(1): 26-29
作者姓名:刘宏艳  薛丽燕  应建明  邱田  邹霜梅  吕宁
作者单位:中国医学科学院肿瘤医院病理科, 北京协和医学院,100021;中国医学科学院肿瘤医院病理科, 北京协和医学院,100021;中国医学科学院肿瘤医院病理科, 北京协和医学院,100021;中国医学科学院肿瘤医院病理科, 北京协和医学院,100021;中国医学科学院肿瘤医院病理科, 北京协和医学院,100021;中国医学科学院肿瘤医院病理科, 北京协和医学院,100021
摘    要:
 【摘要】 目的 探讨BIOMED-2标准化体系检测免疫球蛋白重链(IGH)基因重排对黏膜相关淋巴组织结外边缘区B细胞淋巴瘤(MALT淋巴瘤)诊断的应用价值。方法 45例标本包括不同部位原发的MALT淋巴瘤36例、淋巴结外淋巴组织增生性病变3例、幽门螺杆菌(HP)感染相关性重度胃炎6例。用DNA提取试剂盒从石蜡包埋组织中提取所选病例的基因组DNA,通过BIOMED-2体系质控混合引物检测其质量,应用IGH VH-JH 3组引物组合进行IGH基因克隆性重排检测;比较分析该体系在MALT淋巴瘤诊断中的敏感性和特异性。结果 45例中31例(MALT淋巴瘤22例,淋巴组织增生性病变3例、重度胃炎6例)提取的基因组DNA可扩增出300 bp片段,其余14例DNA均严重降解。22例MALT淋巴瘤中,16例检测出IGH基因重排,灵敏度为72.7 %;6例严重胃炎病例未检测出IGH克隆性重排,其特异度是100 %;3例淋巴组织增生性病变中1例检测出IGH克隆性重排,2例未检测出重排。结论 在MALT淋巴瘤的诊断和淋巴组织增生性疾病的鉴别诊断中,BIOMED-2标准化体系检测IGH基因克隆性重排是一种快速可靠的方法,具有重要的临床应用价值。

关 键 词:基因重排  淋巴瘤  B细胞  边缘区  BIOMED-2体系

Application of BIOMED-2 system for the detection of IGH gene rearrangement in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma diagnosis
LIU Hong-yan , XUE Li-yan , YING Jian-ming , QIU Tian , ZOU Shuang-mei , L Ning. Application of BIOMED-2 system for the detection of IGH gene rearrangement in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma diagnosis[J]. Journal of Leukemia & Lymphoma, 2012, 21(1): 26-29
Authors:LIU Hong-yan    XUE Li-yan    YING Jian-ming    QIU Tian    ZOU Shuang-mei    L Ning
Affiliation:LIU Hong-yan , XUE Li-yan , YING Jian-ming , QIU Tian , ZOU Shuang-mei , L(U) Ning
Abstract:
Objective To evaluate the efficiency of BIOMED-2 system in detecting IGH gene clonal rearrangement and application in diagnosis of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma. Methods Forty-five eases were collected, including 36 MALT lymphomas from different organs, 3 extranodal lymphoid tissue proliferative lesions and 6 severe gastritis associated with H pylori. DNA was extracted from the formalin fixed paraffin embedded blocks of these cases and the quality of DNA was assessed using the BIOMED-2 specimen mixed control primers. IGH gene clonal rearrangement was detected using IGH VH-JH primers. The sensitivity and specificity of BIOMED-2 PCR were analyzed. Results Adequate DNA (≥300 bp) was obtained in 31 of 45 samples (including 22 MALT lymphomas, 3 lymphoid tissue proliferative lesions and 6 severe gastritis), and the DNA from the other 14 samples was degraded seriously. 16 of 22 MALT lymphomas were positive of IGH clonal rearrangement with the sensitivity of 72.7 %. In contrast, none of 6 severe gastritis was positive with the specificity of 100 % IGH and elonal rearrangement were detected in one of 3 lymphoid tissue proliferative lesions. Conclusion BIOMED-2 assay is an efficient and reliable method for diagnosis and differential diagnosis of MALT lymphoma which is important for clinical practical value.
Keywords:Gene rearrangement  Lymphoma,B-cell,marginal zone  BIOMED-2 system
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《白血病.淋巴瘤》浏览原始摘要信息
点击此处可从《白血病.淋巴瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号